JAMA Network
About The Study: Treatment-emergent nirmatrelvir resistance mutations were commonly detected, especially in individuals who were immunosuppressed in this cohort study of 156 participants. However, these mutations were generally present at low frequencies and were transient in nature, suggesting a low risk for the spread of nirmatrelvir resistance in the community with the current variants and drug usage patterns.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
